Karmanos Cancer Institute ( Site 0033)

Detroit, Michigan 48201

0 studies enrolling now · 1 studies all time

What they study most

Clear Cell Renal Cell Carcinoma (ccRCC), Kidney, Kidney Cancer, Renal Cancer, Renal Cell Cancer Metastatic, Renal Cell Cancer, Recurrent, Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Renal Cell Carcinoma Recurrent

Studies at this site

• A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003) — Running, not enrolling